PRESS RELEASE Release Date: 26

th

 April 2010

 

 

 RECORD ATTENDANCE EXPECTED AT UBMS CHINESE PHARMA EVENTS

 

26th April 2010, Amsterdam - Continued double digit growth in the Chinese pharmaceutical industry is 

reflected in record visitor pre-registration levels and a sell-out of exhibition space at this years UBM

International Media China events - CPhI, ICSE, P-MEC and BioPh - which will run from June 2-4 at the

Shanghai New International Expo Centre.

 

Focusing on intermediates and APIs, CPhI China, along with co-located events - P-MEC for equipment,

machinery and technology; ICSE for Contract Services; and, making its debut in China, BioPh for the

biopharma sector - is the largest annual networking event for the Asian pharmaceutical community and

is expected to attract over 20,000 visitors, including 7,000 from outside of China.

 

Projected to be the third largest pharma market globally by 2011 and second by 2020, China is both a

large producer and consumer of medicines, making it an attractive market in terms of both sourcing and

sales. Additional stimuli, such as changes to local GMP standards, which are being revised in 2010 to be

more in line with international ones, are also making China increasingly appealing for Western visitors to

the events, looking to access the many outsourcing and production efficiency partnering opportunities

available in China.